mitochondrial-derived 16-residue peptide
MOTS-c clinical trials
Answer
MOTS-c has 5 registered trials: 4 running, 0 completed, 0 stopped early. 0 posted results.
Trial registerClinicalTrials.gov, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT07678073 Trial register | Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation | currently recruiting participants | - | 2026-07-01 | - |
| NCT07505745 Trial register | MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity | currently recruiting participants | - | 2026-04-01 | - |
| NCT03878706 Trial register | The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination | currently recruiting participants | - | 2019-02-11 | - |
| NCT06133946 Trial register | Cohort Of DEafness-gene Screening | running, but no longer enrolling | - | 2023-11-08 | - |
| NCT04027712 Trial register | Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD | last verified some time ago; the register no longer confirms its status | - | 2019-07-22 | - |
Source: ClinicalTrials.gov, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.